Publications by authors named "Harry Groen"

Claim this Profile
S
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling study.
Koen de Nijs, Kevin Ten Haaf, Juul Hubert, Dana Moldovanu, Carlijn M van der Aalst, Harry J M Groen

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI-treated non-small cell lung cancer patients.
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen

Mol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating High-Risk Individuals Beyond Smoking History Into Lung Cancer Screening in Hong Kong: A Cost-Effectiveness Study.
Herbert Ho-Fung Loong, Xuanqi Pan, Carlos K H Wong, Chao-Hua Chiu, Szu-Chun Yang, Harry Groen

JTO Clin Res Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data.
Noa Antonissen, Kiran Vaidhya Venkadesh, Renate Dinnessen, Ernst Th Scholten, Zaigham Saghir, Harry J M Groen

Radiology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.
Zakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen, Valesca P Retèl, Bram Ramaekers

Clin Drug Investig· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and budget impact of lung cancer screening in time of immunotherapy.
Danrong Zhong, Grigory Sidorenkov, Keris Poelhekken, Yihui Du, Karin M Vermeulen, Harry J M Groen

Lung Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study.
Pim Rozendal, Hanneke Kievit, Paul van der Leest, Idris Bahce, Michiel Pegtel, Harry J M Groen

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials.
Max Welz, Carlijn M van der Aalst, Andreas Alfons, Andrea A Naghi, Marjolein A Heuvelmans, Harry J M Groen

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to 'Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease' [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100813].
Carina M Behr, Maarten J IJzerman, Michelle M A Kip, Harry J M Groen, Marjolein A Heuvelmans

JTO Clin Res Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer screening with volume computed tomography is cost-effective in Greece.
Xuanqi Pan, Katerina Togka, Hilde Ten Berge, Lisa de Jong, Harry Groen

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease.
Carina M Behr, Maarten J IJzerman, Michelle M A Kip, Harry J M Groen, Marjolein A Heuvelmans

JTO Clin Res Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients.
Weiting Li, Fenneke Zwierenga, Katarina D Andini, Justyna M Bucher, Frank Scherpen, Harry J M Groen

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial.
Jürgen Wolf, Maximilian Hochmair, Ji-Youn Han, Noemi Reguart, Pierre-Jean Souquet, Harry J M Groen

Lancet Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial.
Danrong Zhong, Grigory Sidorenkov, Colin Jacobs, Pim A de Jong, Hester A Gietema, Harry J M Groen

Radiology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Solid Lung Nodules Presence and Size by Age and Sex in a Northern European Nonsmoking Population.
Jiali Cai, Marleen Vonder, Gert Jan Pelgrim, Mieneke Rook, Gerdien Kramer, Harry J M Groen

Radiology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Blood CD8 T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer.
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, Abraham Rutgers, Lucie B M Hijmering-Kappelle, Harry J M Groen

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchiectasis is associated with lower lung function in lung cancer screening participants.
Anastasia K A L Kwee, Bart Luijk, Pim A de Jong, Harry J M Groen, Joachim G J V Aerts

Eur Radiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy.
Michael V Martin, Salvador Aguilar-Rosas, Katka Franke, Mark Pieterse, Jamie van Langelaar, Harry J M Groen

Cancer Immunol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who is at risk of lung nodules on low-dose CT in a Western country? A population-based approach.
Jiali Cai, Marleen Vonder, Yihui Du, Gert Jan Pelgrim, Mieneke Rook, Harry J M Groen

Eur Respir J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in frail non-small-cell lung cancer patients.
Rolof Gp Gijtenbeek, Anneloes L Noordhof, Oke D Asmara, Harry Jm Groen, Wouter H van Geffen

Lancet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.
Zakile A Mfumbilwa, Martijn J H G Simons, Bram Ramaekers, Valesca P Retèl, Joanne M Mankor, Harry J M Groen

Pharmacoeconomics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of fat and muscle measurements with emphysema and bronchial wall thickening in smokers.
Stijn A O Bunk, Jetty Ipema, Grigory Sidorenkov, Edwin Bennink, Rozemarijn Vliegenthart, Harry J M Groen

ERJ Open Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes.
Xuanqi Pan, Evgeni Dvortsin, David R Baldwin, Harry J M Groen, Dianne Ramaker

J Med Econ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments.
Fenneke Zwierenga, Bianca A M H van Veggel, Anke van den Berg, Harry J M Groen, Lili Zhang

Cancer Treat Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients.
Paul van der Leest, Melanie Janning, Naomi Rifaela, Maria L Aguirre Azpurua, Jolanthe Kropidlowski, Harry J M Groen

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis